C000201969 Fees and Costs — BlackRock LifePath Index 2020 Fund, Investor P Shares
Data updated: 2019-11-27
The net expense ratio is 0.40% (0.45% before fee waivers). This share class carries a maximum front-end sales load of 5.25%. Portfolio turnover was 20%.
C000201969 Fees and Expenses
Annual operating expenses and sales charges of C000201969. Prospectus, as of April 30, 2019.
| Annual operating expenses | |
|---|---|
| Management fee | 0.05% |
| 12b-1 fee | 0.25% |
| Other expenses | 0.09% |
| Gross expense ratio | 0.45% |
| Fee waiver | −0.05% |
| Net expense ratio | 0.40% |
| Sales charges | |
|---|---|
| Max front load | 5.25% |
| Max deferred load | 0.00% |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | Yes |
C000201969 Costs Over Time
On $10,000 invested in C000201969, assuming 5% a year before costs, total costs come to $910 over 5 years, cutting the return by 1.54% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Sales charges | $525 | $525 | $525 |
| Fund expenses (net expense ratio 0.40%) | $40 | $125 | $218 |
| Lost growth on money paid in costs | $26 | $89 | $167 |
| Total costs | $591 | $739 | $910 |
| Value after costs | $9,909 | $10,837 | $11,853 |
| Impact on return, per year | 5.91% | 2.28% | 1.54% |
C000201969 Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending December 31, 2018.
- Explicit cost rate (commissions ÷ average net assets): —
- Total broker commissions: —
- Bought from dealers (principal trades, not a cost): —
- Portfolio turnover (prospectus): 20%
- Securities lending: none during the year
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.